Friday, July 10, 2026

pharma · Leukemia · Acute Myeloid Leukemia

Shanghai Medical College

Shanghai Medical College trial registry — 21 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
20 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
20
Programs
20
Drugs
22
Patents
0
Intelligence · Clinical Trials

Shanghai Medical College clinical trials

Registry index of 21 ClinicalTrials.gov studies linked to Shanghai Medical College programs — each row shows trial ID, program name, phase, status, and indication.

Shanghai Medical College trial registry — 21 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Shanghai Medical College.

  1. temozolomide — Phase 2

    Clinical update
  2. radiation therapy — Phase 2

    Clinical update
  3. imatinib mesylate — Phase 1

    Clinical update
  4. Doxorubicin Hydrochloride — Phase 2

    Clinical update
  5. doxorubicin hydrochloride — Phase 3

    Clinical update
  6. Carboplatin — Phase 2

    Clinical update
  7. bleomycin sulfate — Phase 2

    Clinical update
  8. Asparaginase — Phase 3

    Clinical update

Trial registry

21 studies